MicroRNA and AU-rich element regulation of prostaglandin synthesis.

MicroRNA and AU-rich element regulation of prostaglandin synthesis.
复制标题

DOI:
10.1007/s10555-011-9300-5
复制
发表时间:
2011-12
影响因子:
9.2
通讯作者:
Dixon, Dan A.
Dixon, Dan A.
中科院分区:
医学2区
文献类型:
--
作者:
Moore, Ashleigh E.;Young, Lisa E.;Dixon, Dan A.

文献摘要

参考文献

被引文献

相似文献

Many liness of evidence demonstrate that prostaglandins play an important role in cancer, and enhanced synthesis of prostaglandin E2 (PGE2) is often observed in various human malignancies often associated with poor prognosis. PGE2 synthesis is initiated with the release of arachidonic acid by phospholipase enzymes, where it is then converted into the intermediate prostaglandin prostaglandin H2 (PGH2) by members of the cyclooxygenase family. The synthesis of PGE2 from PGH2 is facilitated by three different PGE synthases, and functional PGE2 can promote tumor growth by binding to four EP receptors to activate signaling pathways that control cell proliferation, migration, apoptosis, and angiogenesis. An integral method of controlling gene expression is by posttranscriptional mechanisms that regulate mRNA stability and protein translation. Messenger RNA regulatory elements typically reside within the 3′ untranslated region (3′UTR) of the transcript and play a critical role in targeting specific mRNAs for posttranscriptional regulation through micro-RNA (miRNA) binding and adenylate- and uridylate-rich element RNA-binding proteins. In this review, we highlight the current advances in our understanding of the impact these RNA sequence elements have upon regulating PGE2 levels. We also identify various RNA sequence elements consistently observed within the 3′UTRs of the genes involved in the PGE2 pathway, indicating these binding sites for miRNAs and RNA-binding proteins to be central regulators of PGE2 synthesis and function. These findings may provide a rationale for the development of new therapeutic approaches to control tumor growth and metastasis promoted by elevated PGE2 levels.
DOI: 10.1093/nar/gkj052
发表时间: 2006-01-01
影响因子: 14.9
作者:
Bakheet T;Williams BR;Khabar KS
通讯作者: Khabar KS
DOI: 10.1074/jbc.m302474200
发表时间: 2003-09-12
影响因子: 4.8
作者:
Buchanan, FG;Wang, DZ;DuBois, RN
通讯作者: DuBois, RN
DOI: 10.1038/nm.1880
发表时间: 2008-11-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Bonci, Desiree;Coppola, Valeria;De Maria, Ruggero
通讯作者: De Maria, Ruggero
DOI: 10.1002/jcp.20282
发表时间: 2005-07-01
影响因子: 5.6
作者:
Bottoni, A;Piccin, D;Uberti, ECD
通讯作者: Uberti, ECD
DOI: 10.1093/nar/gkm995
发表时间: 2008-01
影响因子: 14.9
作者:
Betel D;Wilson M;Gabow A;Marks DS;Sander C
通讯作者: Sander C